T32 DA007209/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	6
2009	7
2010	6
2011	16
2012	15
2013	18
2014	28
2015	21
2016	27
2017	37
2018	33
2019	36
2020	55
2021	44
2022	37
2023	26
2024	7

1

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR. Davis AK, et al. JAMA Psychiatry. 2021 May 1;78(5):481-489. doi: 10.1001/jamapsychiatry.2020.3285. JAMA Psychiatry. 2021. PMID: 33146667 Free PMC article. Clinical Trial.

2

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Gukasyan N, et al. J Psychopharmacol. 2022 Feb;36(2):151-158. doi: 10.1177/02698811211073759. J Psychopharmacol. 2022. PMID: 35166158 Free PMC article. Clinical Trial.

3

Long-term follow-up of psilocybin-facilitated smoking cessation.

Johnson MW, Garcia-Romeu A, Griffiths RR. Johnson MW, et al. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60. doi: 10.3109/00952990.2016.1170135. Epub 2016 Jul 21. Am J Drug Alcohol Abuse. 2017. PMID: 27441452 Free PMC article. Clinical Trial.

4

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Barrett FS, Griffiths RR. Barrett FS, et al. Curr Top Behav Neurosci. 2018;36:393-430. doi: 10.1007/7854_2017_474. Curr Top Behav Neurosci. 2018. PMID: 28401522 Free PMC article. Review.

5

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy.

Luoma JB, Chwyl C, Bathje GJ, Davis AK, Lancelotta R. Luoma JB, et al. J Psychoactive Drugs. 2020 Sep-Oct;52(4):289-299. doi: 10.1080/02791072.2020.1769878. Epub 2020 Jun 12. J Psychoactive Drugs. 2020. PMID: 32529966 Free PMC article.

6

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. Doss MK, et al. Transl Psychiatry. 2021 Nov 8;11(1):574. doi: 10.1038/s41398-021-01706-y. Transl Psychiatry. 2021. PMID: 34750350 Free PMC article.

7

Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.

Bansal S, Zamarripa CA, Spindle TR, Weerts EM, Thummel KE, Vandrey R, Paine MF, Unadkat JD. Bansal S, et al. Clin Pharmacol Ther. 2023 Sep;114(3):693-703. doi: 10.1002/cpt.2973. Epub 2023 Jun 30. Clin Pharmacol Ther. 2023. PMID: 37313955

8

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Johnson MW, et al. J Psychopharmacol. 2014 Nov;28(11):983-92. doi: 10.1177/0269881114548296. Epub 2014 Sep 11. J Psychopharmacol. 2014. PMID: 25213996 Free PMC article. Clinical Trial.

9

Human behavioral pharmacology of psychedelics.

Strickland JC, Johnson MW. Strickland JC, et al. Adv Pharmacol. 2022;93:105-132. doi: 10.1016/bs.apha.2021.10.003. Epub 2021 Nov 11. Adv Pharmacol. 2022. PMID: 35341564 Review.

10

Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies.

Sholler DJ, Schoene L, Spindle TR. Sholler DJ, et al. Curr Addict Rep. 2020 Sep;7(3):405-412. doi: 10.1007/s40429-020-00326-8. Epub 2020 Jul 25. Curr Addict Rep. 2020. PMID: 33585159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

335 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year